| CAS No.: | 76-22-2 |
|---|---|
| Formula: | 200-945-0 |
| EINECS: | 207-355-2 |
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
| Testing Items | Quality Criterion | Testing Result | |
| 1 | Appearance | White powder crystals | White powder crystals |
| 2 | Identification | Qualified | Qualified |
| 3 | Appearance of solution | Clear | Clear |
| 4 | Non-Volatitle Matter % | ≤0.10 | 0.01 |
| 5 | Melting point (ºC) | 174-179 | 175.0 |
| 6 | Purity % | ≥96.0 | 96.3 |
| 7 | Acidity or alkalinity | Qualified | Qualified |
| CONCLUSION: THE QUALITY IS IN ACCORDANCE WITH DAB-8 | |||
1. Among its side effects, camphor may cause allergic reactions, including drug eruptions and more severe conditions such as exudative erythema multiforme, exfoliative dermatitis, and bullous epidermolysis atrophic dermatitis. Other potential reactions encompass photosensitivity, drug-induced fever, joint and muscle pain, fever, and serum sickness-like symptoms.
2. Some patients may experience hematological issues like neutropenia or deficiency, thrombocytopenia, and aplastic anemia. These conditions manifest through symptoms such as sore throat, fever, pallor, and an increased tendency for bleeding.
3. Hemolytic anemia and hemoglobinuria are potential risks, particularly in individuals with glucose-6-phosphate dehydrogenase deficiency, which is more prevalent in neonates and children. Vigilance is advised when using camphor in these populations.
){kind=link}